A Comprehensive Review of E-service Quality and Comparative Study Between Online Pharmacies in India: 1mg and PharmEasy

Author:

Kumar Ravi1ORCID,Patil Utkarsh2

Affiliation:

1. Upgrad Education Private Limited, Mumbai, Maharashtra, India

2. Liverpool Business School, Liverpool John Moores University, Liverpool, UK

Abstract

E-pharmacies have become the latest trend all over the world, especially since the COVID-19 pandemic started in 2019. While buying online, along with the products/medicines in case of e-pharmacies, people also expect a user-friendly website, prompt and safe delivery, data and payment security, and convenient customer services. Hence, e-pharmacy organizations should satisfy all these factors to be the best in the market, enhance customer experience, and increase customer’s repurchasing intentions. The objective of this research is to compare the e-service quality between two of the top e-pharmacies in India—Tata 1mg and API Holdings Private Limited’s PharmEasy—using the e-service quality hierarchical model developed by Blut (2016). E-service quality is evaluated and compared using the following dimensions: website/application design, customer service, security/privacy, fulfillment, and overall e-service quality from the consumer’s perspective. Findings of the study reveal that there was no significant difference in the quality of dimensions—website design and customer service between 1mg and PharmEasy—while there is a significant difference in the quality of fulfillment, security/privacy, and overall e-service quality between 1mg and PharmEasy.

Publisher

SAGE Publications

Subject

General Medicine

Reference63 articles.

1. Service quality of mHealth platforms: development and validation of a hierarchical model using PLS

2. Consequences Towards E-Pharmacy and its Validated Growth Firms on Herbal and Organic Products

3. Anon. (2021). India e-pharmacy market report 2021: Market stood at $344.78 million in 2021 and is expected to witness robust growth of 21.28% to 2027. https://www.globenewswire.com/news-release/2021/11/23/2339554/28124/en/India-e-Pharmacy-Market-Report-2021-Market-Stood-at-344-78-Million-in-2021-and-is-Expected-to-Witness-Robust-Growth-of-21-28-to-2027.html

4. Appstore-PharmEasy. (2022). PharmEasy: Healthcare app—Ratings and reviews. https://apps.apple.com/us/app/pharmeasy-healthcare-app/id982432643

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3